174 related articles for article (PubMed ID: 29171130)
1. First experience in the UK of treating women with recurrent urinary tract infections with the bacterial vaccine Uromune
Yang B; Foley S
BJU Int; 2018 Feb; 121(2):289-292. PubMed ID: 29171130
[TBL] [Abstract][Full Text] [Related]
2. Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.
Ramírez Sevilla C; Gómez Lanza E; Manzanera JL; Martín JAR; Sanz MÁB
BMC Infect Dis; 2019 Oct; 19(1):901. PubMed ID: 31660885
[TBL] [Abstract][Full Text] [Related]
3. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
Trials; 2016 Jul; 17():358. PubMed ID: 27460108
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.
Lorenzo-Gómez MF; Padilla-Fernández B; García-Cenador MB; Virseda-Rodríguez ÁJ; Martín-García I; Sánchez-Escudero A; Vicente-Arroyo MJ; Mirón-Canelo JA
Front Cell Infect Microbiol; 2015; 5():50. PubMed ID: 26090341
[TBL] [Abstract][Full Text] [Related]
5. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study.
Rudenko N; Dorofeyev A
Arzneimittelforschung; 2005; 55(7):420-7. PubMed ID: 16080282
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of a Sublingual Bacterial Vaccine for the Prophylaxis of Recurrent Urinary Tract Infections.
Carrión-López P; Martínez-Ruiz J; Giménez-Bachs JM; Fernández-Anguita PJ; Díaz de Mera-Sánchez Migallón I; Legido-Gómez O; Rico-Marco S; Lorenzo-Sánchez MV; Salinas-Sánchez AS
Urol Int; 2022; 106(7):730-736. PubMed ID: 35130558
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics.
Lorenzo-Gómez MF; Padilla-Fernández B; García-Criado FJ; Mirón-Canelo JA; Gil-Vicente A; Nieto-Huertos A; Silva-Abuin JM
Int Urogynecol J; 2013 Jan; 24(1):127-34. PubMed ID: 22806485
[TBL] [Abstract][Full Text] [Related]
8. Role of Vaccines for Recurrent Urinary Tract Infections: A Systematic Review.
Prattley S; Geraghty R; Moore M; Somani BK
Eur Urol Focus; 2020 May; 6(3):593-604. PubMed ID: 31806578
[TBL] [Abstract][Full Text] [Related]
9. Re: First Experience in the UK of Treating Women with Recurrent Urinary Tract Infections with the Bacterial Vaccine Uromune
Schaeffer EM
J Urol; 2018 Dec; 200(6):1144-1145. PubMed ID: 30838901
[No Abstract] [Full Text] [Related]
10. Could sublingual vaccination be a viable option for the prevention of recurrent urinary tract infection in Canada? A systematic review of the current literature and plans for the future.
Nickel JC; Saz-Leal P; Doiron RC
Can Urol Assoc J; 2020 Aug; 14(8):281-287. PubMed ID: 33626320
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Efficacy of a Sublingual Bacterial Vaccine in the Prophylaxis of Recurrent Urinary Tract Infection.
Carrión-López P; Martínez-Ruiz J; Librán-García L; Giménez-Bachs JM; Pastor-Navarro H; Salinas-Sánchez AS
Urol Int; 2020; 104(3-4):293-300. PubMed ID: 31962327
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Management of Uncomplicated Recurrent Urinary Tract Infections in a National Sample of Women in the United States.
Suskind AM; Saigal CS; Hanley JM; Lai J; Setodji CM; Clemens JQ;
Urology; 2016 Apr; 90():50-5. PubMed ID: 26825489
[TBL] [Abstract][Full Text] [Related]
13. Research of urinary tract infections in family medicine physicians' offices--empiric antimicrobial therapy of urinary tract infections--Croatian experience.
Skerk V; Skerk V; Jaksić J; Lakos AK; Matrapazovski M; Maleković G; Andrasević AT; Radoaević V; Markotić A; Begovac J
Coll Antropol; 2009 Jun; 33(2):625-31. PubMed ID: 19662789
[TBL] [Abstract][Full Text] [Related]
14. Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial.
Bleidorn J; Hummers-Pradier E; Schmiemann G; Wiese B; Gágyor I
Ger Med Sci; 2016; 14():Doc01. PubMed ID: 26909012
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study.
Zhong YH; Fang Y; Zhou JZ; Tang Y; Gong SM; Ding XQ
J Int Med Res; 2011; 39(6):2335-43. PubMed ID: 22289552
[TBL] [Abstract][Full Text] [Related]
17. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2012 May; 172(9):704-12. PubMed ID: 22782199
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial.
Huttner A; Hatz C; van den Dobbelsteen G; Abbanat D; Hornacek A; Frölich R; Dreyer AM; Martin P; Davies T; Fae K; van den Nieuwenhof I; Thoelen S; de Vallière S; Kuhn A; Bernasconi E; Viereck V; Kavvadias T; Kling K; Ryu G; Hülder T; Gröger S; Scheiner D; Alaimo C; Harbarth S; Poolman J; Fonck VG
Lancet Infect Dis; 2017 May; 17(5):528-537. PubMed ID: 28238601
[TBL] [Abstract][Full Text] [Related]
19. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
[TBL] [Abstract][Full Text] [Related]
20. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT).
Wagenlehner F; Wullt B; Ballarini S; Zingg D; Naber KG
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):107-117. PubMed ID: 28737469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
